Skip to main content
Top
Published in: BMC Cancer 1/2023

Open Access 01-12-2023 | Research

Testicular cancer mortality in Latin America and the Caribbean: trend analysis from 1997 to 2019

Authors: Yuleizy Crispin-Rios, Mariafe Faura-Gonzales, J. Smith Torres-Roman, Carlos Quispe-Vicuña, Uriel S. Franco-Jimenez, Bryan Valcarcel, Andreas Stang, Katherine A. McGlynn

Published in: BMC Cancer | Issue 1/2023

Login to get access

Abstract

Background

In the last decades, an increasing incidence of testicular cancer has been observed in several countries worldwide. Although mortality rates have been variable in many countries, little information is available from Latin America and the Caribbean (LAC). Therefore, we examined mortality trends of testicular cancer in the last two decades.

Methods

Age-standardized mortality rates (ASMR) of testicular cancer per 100,000 men-years were estimated using the World Health Organization mortality database from 1997 to 2019. We examined the mortality trends and computed annual percent change (APC) for all ages and the following age groups, 15–29, 30–44, 15–44, and ≥ 45 years.

Results

Ten countries had mortality rates greater than 0.43 per 100,000 men, with the highest rates for Chile, Mexico, and Argentina. Significant increases in mortality rates were observed in Argentina, Brazil Colombia, and Mexico in all ages, and < 45 years, while Colombia, Ecuador, Mexico, and Peru reported significant downward trends in males aged ≥ 45 years. Only Chile showed significant decreases for all ages and age groups studied.

Conclusion

Mortality by testicular cancer increased among LAC countries in males of all ages and across age groups. A reduction in mortality rates was observed only in Chilean males of all ages and in men ≥ 45 years in several countries. Strengthening of early detection among symptomatic males may decrease the mortality by this neoplasm.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kusler KA, Poynter JN. International testicular cancer incidence rates in children, adolescents and young adults. Cancer Epidemiol. 2018;56:106–11.CrossRefPubMed Kusler KA, Poynter JN. International testicular cancer incidence rates in children, adolescents and young adults. Cancer Epidemiol. 2018;56:106–11.CrossRefPubMed
2.
go back to reference Znaor A, Lortet-Tieulent J, Jemal A, Bray F. International variations and trends in testicular cancer incidence and mortality. Eur Urol. 2014;65(6):1095–106.CrossRefPubMed Znaor A, Lortet-Tieulent J, Jemal A, Bray F. International variations and trends in testicular cancer incidence and mortality. Eur Urol. 2014;65(6):1095–106.CrossRefPubMed
3.
go back to reference Znaor A, Skakkebæk NE, Rajpert-De Meyts E, Laversanne M, Kuliš T, Gurney J, Sarfati D, McGlynn KA, Bray F. Testicular cancer incidence predictions in Europe 2010–2035: A rising burden despite population ageing. Int J Cancer. 2020;147(3):820–8.CrossRefPubMed Znaor A, Skakkebæk NE, Rajpert-De Meyts E, Laversanne M, Kuliš T, Gurney J, Sarfati D, McGlynn KA, Bray F. Testicular cancer incidence predictions in Europe 2010–2035: A rising burden despite population ageing. Int J Cancer. 2020;147(3):820–8.CrossRefPubMed
4.
go back to reference Rosen A, Jayram G, Drazer M, Eggener SE. Global trends in testicular cancer incidence and mortality. Eur Urol. 2011;60(2):374–9.CrossRefPubMed Rosen A, Jayram G, Drazer M, Eggener SE. Global trends in testicular cancer incidence and mortality. Eur Urol. 2011;60(2):374–9.CrossRefPubMed
5.
go back to reference Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin 2021, 71(3):209–249. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin 2021, 71(3):209–249.
6.
go back to reference Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. 2020. [Cited 11 March, 2023]. Available from: https://gco.iarc.fr/today. Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. 2020. [Cited 11 March, 2023]. Available from: https://​gco.​iarc.​fr/​today.
7.
go back to reference Stang A, Bray F, Dieckmann K-P, Lortet-Tieulent J, Rusner C. Mortality of testicular cancer in east and west Germany 20 years after reunification: a gap not closed yet. Urol Int. 2015;95(2):160–6.CrossRefPubMed Stang A, Bray F, Dieckmann K-P, Lortet-Tieulent J, Rusner C. Mortality of testicular cancer in east and west Germany 20 years after reunification: a gap not closed yet. Urol Int. 2015;95(2):160–6.CrossRefPubMed
8.
go back to reference McGlynn KA. Environmental and host factors in testicular germ cell tumors. Cancer Invest. 2001;19(8):842–53.CrossRefPubMed McGlynn KA. Environmental and host factors in testicular germ cell tumors. Cancer Invest. 2001;19(8):842–53.CrossRefPubMed
9.
go back to reference Garner MJ, Turner MC, Ghadirian P, Krewski D. Epidemiology of testicular cancer: an overview. Int J Cancer. 2005;116(3):331–9.CrossRefPubMed Garner MJ, Turner MC, Ghadirian P, Krewski D. Epidemiology of testicular cancer: an overview. Int J Cancer. 2005;116(3):331–9.CrossRefPubMed
10.
go back to reference Dieckmann K-P, Pichlmeier U. Clinical epidemiology of testicular germ cell tumors. World J Urol. 2004;22(1):2–14.CrossRefPubMed Dieckmann K-P, Pichlmeier U. Clinical epidemiology of testicular germ cell tumors. World J Urol. 2004;22(1):2–14.CrossRefPubMed
12.
go back to reference McGlynn KA, Cook MB. Etiologic factors in testicular germ-cell tumors. Future Oncol. 2009;5(9):1389–402.CrossRefPubMed McGlynn KA, Cook MB. Etiologic factors in testicular germ-cell tumors. Future Oncol. 2009;5(9):1389–402.CrossRefPubMed
13.
go back to reference Schnack TH, Poulsen G, Myrup C, Wohlfahrt J, Melbye M. Familial coaggregation of cryptorchidism, hypospadias, and testicular germ cell cancer: a nationwide cohort study. J Natl Cancer Inst. 2010;102(3):187–92.CrossRefPubMed Schnack TH, Poulsen G, Myrup C, Wohlfahrt J, Melbye M. Familial coaggregation of cryptorchidism, hypospadias, and testicular germ cell cancer: a nationwide cohort study. J Natl Cancer Inst. 2010;102(3):187–92.CrossRefPubMed
14.
go back to reference Grulich AE, Van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370(9581):59–67.CrossRefPubMed Grulich AE, Van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370(9581):59–67.CrossRefPubMed
15.
go back to reference Holm M, Hoei-Hansen CE, Rajpert-De Meyts E, Skakkebaek NE: Increased risk of carcinoma in situ in patients with testicular germ cell cancer with ultrasonic microlithiasis in the contralateral testicle. J Urol 2003;170(4 Part 1):1163–1167. Holm M, Hoei-Hansen CE, Rajpert-De Meyts E, Skakkebaek NE: Increased risk of carcinoma in situ in patients with testicular germ cell cancer with ultrasonic microlithiasis in the contralateral testicle. J Urol 2003;170(4 Part 1):1163–1167.
17.
go back to reference Dieckmann K-P, Rube C, Henke R-P. Association of Down’s syndrome and testicular cancer. J Urol. 1997;157(5):1701–4.CrossRefPubMed Dieckmann K-P, Rube C, Henke R-P. Association of Down’s syndrome and testicular cancer. J Urol. 1997;157(5):1701–4.CrossRefPubMed
18.
go back to reference Garner MJ, Birkett NJ, Johnson KC, Shatenstein B, Ghadirian P, Krewski D. Group CCRER: Dietary risk factors for testicular carcinoma. Int J Cancer. 2003;106(6):934–41.CrossRefPubMed Garner MJ, Birkett NJ, Johnson KC, Shatenstein B, Ghadirian P, Krewski D. Group CCRER: Dietary risk factors for testicular carcinoma. Int J Cancer. 2003;106(6):934–41.CrossRefPubMed
19.
go back to reference Gurney J, Shaw C, Stanley J, Signal V, Sarfati D. Cannabis exposure and risk of testicular cancer: a systematic review and meta-analysis. BMC Cancer. 2015;15(1):897.CrossRefPubMedPubMedCentral Gurney J, Shaw C, Stanley J, Signal V, Sarfati D. Cannabis exposure and risk of testicular cancer: a systematic review and meta-analysis. BMC Cancer. 2015;15(1):897.CrossRefPubMedPubMedCentral
20.
go back to reference Powles T, Bower M, Daugaard G, Shamash J, De Ruiter A, Johnson M, Fisher M, Anderson J, Mandalia S, Stebbing J. Multicenter study of human immunodeficiency virus–related germ cell tumors. J Clin Oncol. 2003;21(10):1922–7.CrossRefPubMed Powles T, Bower M, Daugaard G, Shamash J, De Ruiter A, Johnson M, Fisher M, Anderson J, Mandalia S, Stebbing J. Multicenter study of human immunodeficiency virus–related germ cell tumors. J Clin Oncol. 2003;21(10):1922–7.CrossRefPubMed
21.
go back to reference Gurney JK, Florio AA, Znaor A, Ferlay J, Laversanne M, Sarfati D, Bray F, McGlynn KA. International trends in the incidence of testicular cancer: lessons from 35 years and 41 countries. Eur Urol. 2019;76(5):615–23.CrossRefPubMedPubMedCentral Gurney JK, Florio AA, Znaor A, Ferlay J, Laversanne M, Sarfati D, Bray F, McGlynn KA. International trends in the incidence of testicular cancer: lessons from 35 years and 41 countries. Eur Urol. 2019;76(5):615–23.CrossRefPubMedPubMedCentral
22.
go back to reference Quezada AD, Lozada-Tequeanes AL. Time trends and sex differences in associations between socioeconomic status indicators and overweight-obesity in Mexico (2006–2012). BMC Public Health. 2015;15(1):1244.CrossRefPubMedPubMedCentral Quezada AD, Lozada-Tequeanes AL. Time trends and sex differences in associations between socioeconomic status indicators and overweight-obesity in Mexico (2006–2012). BMC Public Health. 2015;15(1):1244.CrossRefPubMedPubMedCentral
23.
go back to reference World Health Organization. International Classification of Disease and Related Health Problems: 10th Revision. Geneva, vol. 1: World Health Organization; 1992. World Health Organization. International Classification of Disease and Related Health Problems: 10th Revision. Geneva, vol. 1: World Health Organization; 1992.
27.
go back to reference Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335–51.CrossRefPubMed Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335–51.CrossRefPubMed
28.
go back to reference Huang J, Chan SC, Tin MS, Liu X. Lok VT-T, Ngai CH, Zhang L, Lucero-Prisno III DE, Xu W, Zheng Z-J: Worldwide Distribution, Risk Factors, and Temporal Trends of Testicular Cancer Incidence and Mortality: A Global Analysis. Eur Urol Oncol. 2022;5(5):566–76. Huang J, Chan SC, Tin MS, Liu X. Lok VT-T, Ngai CH, Zhang L, Lucero-Prisno III DE, Xu W, Zheng Z-J: Worldwide Distribution, Risk Factors, and Temporal Trends of Testicular Cancer Incidence and Mortality: A Global Analysis. Eur Urol Oncol. 2022;5(5):566–76.
29.
go back to reference Greiman AK, Rosoff JS, Prasad SM. Association of Human Development Index with global bladder, kidney, prostate and testis cancer incidence and mortality. BJU Int. 2017;120(6):799–807.CrossRefPubMed Greiman AK, Rosoff JS, Prasad SM. Association of Human Development Index with global bladder, kidney, prostate and testis cancer incidence and mortality. BJU Int. 2017;120(6):799–807.CrossRefPubMed
30.
go back to reference Piñeros M, Abriata MG, Mery L, Bray F. Cancer registration for cancer control in Latin America: a status and progress report. Rev Panam Salud Publica. 2018;41: e2. Piñeros M, Abriata MG, Mery L, Bray F. Cancer registration for cancer control in Latin America: a status and progress report. Rev Panam Salud Publica. 2018;41: e2.
31.
go back to reference Miki J, Rampatige R, Richards N, Adair T, Cortez-Escalante J, Vargas-Herrera J. Saving lives through certifying deaths: assessing the impact of two interventions to improve cause of death data in Perú. BMC Public Health. 2018;18(1):1–11.CrossRef Miki J, Rampatige R, Richards N, Adair T, Cortez-Escalante J, Vargas-Herrera J. Saving lives through certifying deaths: assessing the impact of two interventions to improve cause of death data in Perú. BMC Public Health. 2018;18(1):1–11.CrossRef
32.
go back to reference Atun R, De Andrade LOM, Almeida G, Cotlear D, Dmytraczenko T, Frenz P, Garcia P, Gómez-Dantés O, Knaul FM, Muntaner C. Health-system reform and universal health coverage in Latin America. Lancet. 2015;385(9974):1230–47.CrossRefPubMed Atun R, De Andrade LOM, Almeida G, Cotlear D, Dmytraczenko T, Frenz P, Garcia P, Gómez-Dantés O, Knaul FM, Muntaner C. Health-system reform and universal health coverage in Latin America. Lancet. 2015;385(9974):1230–47.CrossRefPubMed
33.
go back to reference Markt SC, Lago-Hernandez CA, Miller RE, Mahal BA, Bernard B, Albiges L, Frazier LA, Beard CJ, Wright AA, Sweeney CJ. Insurance status and disparities in disease presentation, treatment, and outcomes for men with germ cell tumors. Cancer. 2016;122(20):3127–35.CrossRefPubMed Markt SC, Lago-Hernandez CA, Miller RE, Mahal BA, Bernard B, Albiges L, Frazier LA, Beard CJ, Wright AA, Sweeney CJ. Insurance status and disparities in disease presentation, treatment, and outcomes for men with germ cell tumors. Cancer. 2016;122(20):3127–35.CrossRefPubMed
34.
go back to reference Kamel MH, Elfaramawi M, Jadhav S, Saafan A, Raheem OA, Davis R. Insurance status and differences in treatment and survival of testicular cancer patients. Urology. 2016;87:140–5.CrossRefPubMed Kamel MH, Elfaramawi M, Jadhav S, Saafan A, Raheem OA, Davis R. Insurance status and differences in treatment and survival of testicular cancer patients. Urology. 2016;87:140–5.CrossRefPubMed
35.
go back to reference Piñeros M, Laversanne M, Barrios E, de Camargo CM, de Vries E, Pardo C, Bray F. An updated profile of the cancer burden, patterns and trends in Latin America and the Caribbean. Lancet Reg Health Am. 2022;13: 100294.PubMedPubMedCentral Piñeros M, Laversanne M, Barrios E, de Camargo CM, de Vries E, Pardo C, Bray F. An updated profile of the cancer burden, patterns and trends in Latin America and the Caribbean. Lancet Reg Health Am. 2022;13: 100294.PubMedPubMedCentral
36.
go back to reference Barrios CH, Werutsky G, Mohar A, Ferrigno AS, Müller BG, Bychkovsky BL, Uribe CJ, Villarreal-Garza C, Soto-Perez-de-Celis E, Gutiérrez-Delgado F. Cancer control in Latin America and the Caribbean: recent advances and opportunities to move forward. Lancet Oncol. 2021;22(11):e474–87.CrossRefPubMed Barrios CH, Werutsky G, Mohar A, Ferrigno AS, Müller BG, Bychkovsky BL, Uribe CJ, Villarreal-Garza C, Soto-Perez-de-Celis E, Gutiérrez-Delgado F. Cancer control in Latin America and the Caribbean: recent advances and opportunities to move forward. Lancet Oncol. 2021;22(11):e474–87.CrossRefPubMed
37.
go back to reference Strasser-Weippl K, Chavarri-Guerra Y, Villarreal-Garza C, Bychkovsky BL, Debiasi M, Liedke PE, Soto-Perez-de-Celis E, Dizon D, Cazap E, de Lima Lopes Jr G,. Progress and remaining challenges for cancer control in Latin America and the Caribbean. Lancet Oncol. 2015;16(14):1405–38.CrossRefPubMed Strasser-Weippl K, Chavarri-Guerra Y, Villarreal-Garza C, Bychkovsky BL, Debiasi M, Liedke PE, Soto-Perez-de-Celis E, Dizon D, Cazap E, de Lima Lopes Jr G,. Progress and remaining challenges for cancer control in Latin America and the Caribbean. Lancet Oncol. 2015;16(14):1405–38.CrossRefPubMed
39.
go back to reference Znaor A, Skakkebaek NE, Rajpert‐De Meyts E, Kuliš T, Laversanne M, Gurney J, Sarfati D, McGlynn KA, Bray F: Global patterns in testicular cancer incidence and mortality in 2020. Int J Cancer 2022. Znaor A, Skakkebaek NE, Rajpert‐De Meyts E, Kuliš T, Laversanne M, Gurney J, Sarfati D, McGlynn KA, Bray F: Global patterns in testicular cancer incidence and mortality in 2020. Int J Cancer 2022.
Metadata
Title
Testicular cancer mortality in Latin America and the Caribbean: trend analysis from 1997 to 2019
Authors
Yuleizy Crispin-Rios
Mariafe Faura-Gonzales
J. Smith Torres-Roman
Carlos Quispe-Vicuña
Uriel S. Franco-Jimenez
Bryan Valcarcel
Andreas Stang
Katherine A. McGlynn
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2023
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-023-11511-z

Other articles of this Issue 1/2023

BMC Cancer 1/2023 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine